222 related articles for article (PubMed ID: 21604764)
1. Acute hypertriglyceridemia promotes intestinal lymphatic lipid and drug transport: a positive feedback mechanism in lipid and drug absorption.
Trevaskis NL; Charman WN; Porter CJ
Mol Pharm; 2011 Aug; 8(4):1132-9. PubMed ID: 21604764
[TBL] [Abstract][Full Text] [Related]
2. The lymph lipid precursor pool is a key determinant of intestinal lymphatic drug transport.
Trevaskis NL; Porter CJ; Charman WN
J Pharmacol Exp Ther; 2006 Feb; 316(2):881-91. PubMed ID: 16249368
[TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36.
Hsieh J; Longuet C; Maida A; Bahrami J; Xu E; Baker CL; Brubaker PL; Drucker DJ; Adeli K
Gastroenterology; 2009 Sep; 137(3):997-1005, 1005.e1-4. PubMed ID: 19482026
[TBL] [Abstract][Full Text] [Related]
4. Acute-on-chronic effects of fatty acids on intestinal triacylglycerol-rich lipoprotein metabolism.
Black IL; Roche HM; Tully AM; Gibney MJ
Br J Nutr; 2002 Dec; 88(6):661-9. PubMed ID: 12493088
[TBL] [Abstract][Full Text] [Related]
5. Lymphatic transport of halofantrine in the triple-cannulated anesthetized rat model: effect of lipid vehicle dispersion.
Porter CJ; Charman SA; Charman WN
J Pharm Sci; 1996 Apr; 85(4):351-6. PubMed ID: 8901067
[TBL] [Abstract][Full Text] [Related]
6. [The lipid metabolism of the small intestine and its correlation to the lipid and lipoprotein metabolism of the total organism].
Gangl A
Acta Med Austriaca Suppl; 1975; 2():1-49. PubMed ID: 1065179
[TBL] [Abstract][Full Text] [Related]
7. Intestinal lymphatic transport of halofantrine in rats assessed using a chylomicron flow blocking approach: the influence of polysorbate 60 and 80.
Lind ML; Jacobsen J; Holm R; Müllertz A
Eur J Pharm Sci; 2008 Oct; 35(3):211-8. PubMed ID: 18675904
[TBL] [Abstract][Full Text] [Related]
8. An examination of the interplay between enterocyte-based metabolism and lymphatic drug transport in the rat.
Trevaskis NL; Porter CJ; Charman WN
Drug Metab Dispos; 2006 May; 34(5):729-33. PubMed ID: 16467133
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a chylomicron flow blocking approach to investigate the intestinal lymphatic transport of lipophilic drugs.
Dahan A; Hoffman A
Eur J Pharm Sci; 2005 Mar; 24(4):381-8. PubMed ID: 15734305
[TBL] [Abstract][Full Text] [Related]
10. Lymphatic transport of halofantrine in the conscious rat when administered as either the free base or the hydrochloride salt: effect of lipid class and lipid vehicle dispersion.
Porter CJ; Charman SA; Humberstone AJ; Charman WN
J Pharm Sci; 1996 Apr; 85(4):357-61. PubMed ID: 8901068
[TBL] [Abstract][Full Text] [Related]
11. Uptake of lipophilic drugs by plasma derived isolated chylomicrons: linear correlation with intestinal lymphatic bioavailability.
Gershkovich P; Hoffman A
Eur J Pharm Sci; 2005 Dec; 26(5):394-404. PubMed ID: 16140514
[TBL] [Abstract][Full Text] [Related]
12. Intestinal triglycerides are derived from both endogenous and exogenous sources.
Shiau YF; Popper DA; Reed M; Umstetter C; Capuzzi D; Levine GM
Am J Physiol; 1985 Feb; 248(2 Pt 1):G164-9. PubMed ID: 3970197
[TBL] [Abstract][Full Text] [Related]
13. Examination of lymphatic transport of puerarin in unconscious lymph duct-cannulated rats after administration in microemulsion drug delivery systems.
Wu H; Zhou A; Lu C; Wang L
Eur J Pharm Sci; 2011 Mar; 42(4):348-53. PubMed ID: 21216284
[TBL] [Abstract][Full Text] [Related]
14. The influence of intestinal lymphatic transport on the systemic exposure and brain deposition of a novel highly lipophilic compound with structural similarity to cholesterol.
Caliph SM; Faassen FW; Porter CJ
J Pharm Pharmacol; 2014 Oct; 66(10):1377-87. PubMed ID: 24821499
[TBL] [Abstract][Full Text] [Related]
15. Altered triglyceride-rich lipoprotein production in Zucker diabetic fatty rats.
Chirieac DV; Collins HL; Cianci J; Sparks JD; Sparks CE
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E42-9. PubMed ID: 14970003
[TBL] [Abstract][Full Text] [Related]
16. Triglyceride-rich lipoproteins and cytosolic lipid droplets in enterocytes: key players in intestinal physiology and metabolic disorders.
Demignot S; Beilstein F; Morel E
Biochimie; 2014 Jan; 96():48-55. PubMed ID: 23871915
[TBL] [Abstract][Full Text] [Related]
17. Triglycerides and gallstone formation.
Smelt AH
Clin Chim Acta; 2010 Nov; 411(21-22):1625-31. PubMed ID: 20699090
[TBL] [Abstract][Full Text] [Related]
18. Intestinal lipoprotein formation: effect of cholchicine.
Glickman RM; Perrotto JL; Kirsch K
Gastroenterology; 1976 Mar; 70(3):347-52. PubMed ID: 765186
[TBL] [Abstract][Full Text] [Related]
19. Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats.
Caliph SM; Charman WN; Porter CJ
J Pharm Sci; 2000 Aug; 89(8):1073-84. PubMed ID: 10906731
[TBL] [Abstract][Full Text] [Related]
20. Very low density lipoproteins in intestinal lymph: role in triglyceride and cholesterol transport during fat absorption.
Ockner RK; Hughes FB; Isselbacher KJ
J Clin Invest; 1969 Dec; 48(12):2367-73. PubMed ID: 5355348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
